Prognostic Value of Promoter Hypermethylation of Retinoic Acid Receptor Beta (RARB) and CDKN2 (p16/MTS1) in Prostate Cancer.

Autor: Ameri A; Department of Radiation Oncology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran;, Alidoosti A, Hosseini SY, Parvin M, Emranpour MH, Taslimi F, Salehi E, Fadavip P

Publikováno v: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu [Chin J Cancer Res] 2011 Dec; Vol. 23 (4), pp. 306-11.